Through powerful research, the Melanoma Research Alliance (MRA) is quickly delivering results and saving lives. In ten years, the Melanoma Research Alliance has become the largest, non-profit funder of melanoma research worldwide. In fact, with Tuesday's announcement of 28 new grant awards – MRA has now funded $100 million in the areas of prevention, diagnosis, and treatment!
Read More
Melanoma is the deadliest form of skin cancer. Rates of melanoma are rising rapidly, especially in younger people. In fact, cases of melanoma have tripled in the last 30 years, at a time when cancer rates for other common cancers have declined.
Do you know the answer to these top ten questions people ask about melanoma?
Dr. Patrick Ott, Clinical Director of the Melanoma Center at the Dana-Farber Cancer Institute and lead researcher on the BJ's Wholesale Club-MRA Team Science Award, is conducting pioneering research to harness the power of personalized vaccines to combat melanoma.
Read More
Brain metastases (mets) are a frequent and often deadly problem in patients with advanced melanoma. Nearly 40% of patients with metastatic melanoma have brain mets at diagnosis, with an average survival of only 4 months, highlighting a crucial need for treatments that can rid the brain of these tumors. Fortunately, MRA-funded researchers are making headway in understanding brain mets and how to best treat them.
Read More
05/24/2018 – Leveraged Finance Industry Raises Record $2 million for Life-Saving Melanoma Research
05/10/2018 – New Grants Totaling $2.6 Million Fund Work to Reduce Immunotherapy Side Effects
04/24/2018 – Melanoma Research Alliance Announces $11.8 Million in 28 New Grants to Advance Melanoma Research
02/20/2018 – Melanoma is Determined, So is Eric
